In vitro biocompatibility of fluorcanasite glass-ceramics for bone tissue repair

被引:36
作者
Bandyopadhyay-Ghosh, S.
Reaney, I. M.
Brook, I. M.
Hurrell-Gillingham, K.
Johnson, A.
Hatton, P. V.
机构
[1] Univ Sheffield, Dept Engn Mat, Sheffield S1 3JD, S Yorkshire, England
[2] Univ Sheffield, Ctr Biomat & Tissue Engn, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England
关键词
glass-ceramic; bioceramic; chain silicate; fluorcanasite; frankamenite; fluorapatite; biocompatibility; bone; osteoconductivity;
D O I
10.1002/jbm.a.30878
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Fluorcanasite glass-ceramics were produced by controlled two stage heat-treatment of as-cast glasses. These glasses were modified from stoichiometric fluorcanasite composition by either adding P2O5 or altering the molar ratios of Na2O and CaO. Commercial bioactive 45S5 Bioglass (R) was also prepared in-house to evaluate the relative in vitro biocompatibility of fluorcanasite glass-ceramics. The scanning electron microscopy (SEM) images showed that cells had colonized the surfaces of fluorcanasite glass-ceramics to form a confluent sheet. Quantitative MTT assay results were in good agreement with the qualitative SEM observations. It was concluded that incorporation of excess calcium oxide or P2O5 in stoichiometric glass composition improved in vitro biocompatibility. Controlled heat-treatment further improved the biological response of cultured bone cells to modified fluorcanasite glass-ceramics when compared with their parent glasses. Ion release and pH data suggested a strong correlation between solubility (in particular, Na ion release) and biocompatibility. Reduced solubility, Na ion release, and related pH effects appeared to be the principal mechanisms responsible for improvement in in vitro biocompatibility. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 17 条
[1]
CHAIN SILICATE GLASS-CERAMICS [J].
BEALL, GH .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 1991, 129 (1-3) :163-173
[2]
Glass-ionomers: bioactive implant materials [J].
Brook, IM ;
Hatton, PV .
BIOMATERIALS, 1998, 19 (06) :565-571
[3]
Role of exchanged ions in the integration of ionomeric (glass polyalkenoate) bone substitutes [J].
Carter, DH ;
Sloan, P ;
Brook, IM ;
Hatton, PV .
BIOMATERIALS, 1997, 18 (06) :459-466
[4]
Dependence of in vitro biocompatibility of ionomeric cements on ion release [J].
Devlin, AJ ;
Hatton, PV ;
Brook, IM .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1998, 9 (12) :737-741
[5]
Gross U, 1987, BIOMATERIALS CLIN AP, P547
[6]
BIOCERAMICS - FROM CONCEPT TO CLINIC [J].
HENCH, LL .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1991, 74 (07) :1487-1510
[7]
HENCH LL, 1982, BIOMATERIALS INTERFA, P1
[8]
APATITE MULLITE GLASS-CERAMICS [J].
HILL, R ;
WOOD, D .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1995, 6 (06) :311-318
[9]
Early stages of crystallization in canasite-based glass ceramics [J].
Kanchanarat, N ;
Miller, CA ;
Hatton, PV ;
James, PF ;
Reaney, IM .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 2005, 88 (11) :3198-3204
[10]
Kokubo T., 1993, An introduction to bioceramics, P75, DOI https://doi.org/10.1142/9789814317351_0005